FLUTICASONE FUROATE

FLUTICASONE FUROATE was reported 43081 times

FLUTICASONE FUROATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BILE ACIDS 8 0.8889
1 PITUITARY STALK INTERRUPTION SYNDROME 11 0.7333
2 PLETHYSMOGRAPHY 17 0.6538
3 APPENDICOLITH 154 0.3979
4 SARS-COV-2 SEPSIS 14 0.3889
5 VAGINAL FLATULENCE 114 0.3762
6 MALIGNANT MEDIASTINAL NEOPLASM 41 0.3727
7 CONGENITAL PHARYNGEAL ANOMALY 9 0.3600
8 RADIOALLERGOSORBENT TEST POSITIVE 10 0.3571
9 HYPER IGE SYNDROME 38 0.3333
10 SLEEP DISORDER THERAPY 64 0.3232
11 BIOPSY TONGUE 8 0.2667
12 ANTACID THERAPY 34 0.2615
13 ANALGESIC THERAPY 68 0.2118
14 BRONCHIAL NEOPLASM 25 0.1838
15 DRUG THERAPY 62 0.1829
16 TOTAL LUNG CAPACITY INCREASED 42 0.1544
17 BIOPSY CERVIX 8 0.1538
18 FORCED EXPIRATORY VOLUME INCREASED 9 0.1525
19 FUNGAL DISEASE CARRIER 15 0.1485
20 BACTEROIDES INFECTION 34 0.1303
21 CARBUNCLE 34 0.1201
22 ANTICOAGULANT THERAPY 33 0.1162
23 MALIGNANT MELANOMA STAGE 0 21 0.1005
24 LUNG DIFFUSION DISORDER 15 0.0955
25 CONGENITAL HIATUS HERNIA 21 0.0921
26 BRONCHIAL HAEMORRHAGE 26 0.0833
27 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 41 0.0784
28 FORCED EXPIRATORY VOLUME ABNORMAL 11 0.0759
29 FEMALE GENITAL TRACT FISTULA 119 0.0696
30 NASAL TURBINATE HYPERTROPHY 26 0.0690
31 ENDOMETRIAL ABLATION 24 0.0672
32 EOSINOPHILIC BRONCHITIS 13 0.0650
33 RESPIRATORY GAS EXCHANGE DISORDER 24 0.0647
34 CHRONIC SINUSITIS 240 0.0639
35 IMMUNE-MEDIATED NEPHRITIS 29 0.0618
36 SECONDARY HYPOGONADISM 20 0.0606
37 BREAST CONSERVING SURGERY 30 0.0586
38 NSAID EXACERBATED RESPIRATORY DISEASE 21 0.0556
39 EOSINOPHILIC PNEUMONIA CHRONIC 16 0.0539
40 MACULAR DEGENERATION 636 0.0532
41 TRISOMY 18 19 0.0499
42 MONOCLONAL IMMUNOGLOBULIN PRESENT 34 0.0447
43 INGUINAL HERNIA REPAIR 15 0.0446
44 BLOOD PHOSPHORUS INCREASED 122 0.0446
45 RADICULOPATHY 116 0.0440
46 VICTIM OF CHILD ABUSE 11 0.0438
47 ATOPY 12 0.0432
48 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 39 0.0421
49 PROCTITIS 116 0.0414
50 RESTRICTIVE PULMONARY DISEASE 47 0.0401
51 HYPERPHOSPHATAEMIA 84 0.0390
52 WRIST DEFORMITY 21 0.0341
53 OBSTRUCTIVE AIRWAYS DISORDER 379 0.0340
54 REVERSIBLE AIRWAYS OBSTRUCTION 17 0.0335
55 RHONCHI 44 0.0318
56 DYSBIOSIS 26 0.0317
57 HYPOTHALAMO-PITUITARY DISORDER 46 0.0316
58 NASAL OBSTRUCTION 59 0.0314
59 FULL BLOOD COUNT ABNORMAL 330 0.0312
60 POLYCYSTIC OVARIES 48 0.0309
61 BLOOD IMMUNOGLOBULIN E INCREASED 74 0.0305
62 BLEPHAROSPASM 191 0.0303
63 LUNG HYPERINFLATION 25 0.0291
64 EPIDURAL LIPOMATOSIS 10 0.0291
65 INJECTION SITE SCAB 28 0.0290
66 NASAL POLYPS 139 0.0282
67 BLOOD ALKALINE PHOSPHATASE ABNORMAL 25 0.0278
68 TOTAL LUNG CAPACITY DECREASED 44 0.0275
69 ALTERNARIA INFECTION 10 0.0269
70 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 16 0.0260
71 LUNG OPACITY 68 0.0258
72 GINGIVAL ABSCESS 19 0.0252
73 NASAL SEPTAL OPERATION 9 0.0249
74 MITE ALLERGY 16 0.0244
75 TRICHOGLOSSIA 10 0.0244
76 MUSCLE MASS 11 0.0243
77 OVERLAP SYNDROME 17 0.0243
78 THROAT CLEARING 88 0.0235
79 TOTAL LUNG CAPACITY ABNORMAL 9 0.0231
80 BRONCHIECTASIS 154 0.0228
81 NASAL OEDEMA 41 0.0227
82 PRODUCT COMPLAINT 539 0.0213
83 PLICATED TONGUE 10 0.0210
84 DUST ALLERGY 20 0.0204
85 BRONCHIAL DISORDER 31 0.0199
86 LUPUS VULGARIS 25 0.0198
87 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 40 0.0196
88 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 329 0.0194
89 FORCED EXPIRATORY VOLUME DECREASED 54 0.0190
90 ASTHMATIC CRISIS 69 0.0189
91 PULMONARY VASCULITIS 10 0.0186
92 PNEUMONIA HAEMOPHILUS 9 0.0185
93 SPIROMETRY ABNORMAL 11 0.0184
94 FORCED VITAL CAPACITY DECREASED 12 0.0184
95 TONGUE ERUPTION 9 0.0181
96 IRON DEFICIENCY 80 0.0178
97 OROPHARYNGEAL CANDIDIASIS 16 0.0177
98 SUBCLAVIAN VEIN THROMBOSIS 20 0.0176
99 FOETAL MALFORMATION 19 0.0175
100 BLOOD URIC ACID INCREASED 101 0.0175
101 RHINITIS ALLERGIC 75 0.0168
102 APPENDICITIS 156 0.0167
103 SYPHILIS 12 0.0165
104 HAEMOPHILUS INFECTION 16 0.0163
105 TONGUE PRURITUS 14 0.0163
106 SPUTUM DISCOLOURED 151 0.0159
107 DYSLIPIDAEMIA 80 0.0157
108 WHEEZING 921 0.0155
109 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 9 0.0154
110 C-REACTIVE PROTEIN 14 0.0151
111 PAROTITIS 17 0.0146
112 SCIATIC NERVE INJURY 12 0.0144
113 FACET JOINT SYNDROME 47 0.0144
114 STEROID DIABETES 21 0.0140
115 PORPHYRIA ACUTE 20 0.0139
116 PRODUCT CONFUSION 11 0.0139
117 RESPIRATORY SYMPTOM 39 0.0137
118 VENTRICULAR FIBRILLATION 152 0.0137
119 AMBLYOPIA 8 0.0135
120 AORTIC STENOSIS 47 0.0135
121 EOSINOPHIL COUNT ABNORMAL 10 0.0134
122 BREATH SOUNDS ABNORMAL 65 0.0132
123 MYASTHENIA GRAVIS 105 0.0130
124 DEEP VEIN THROMBOSIS POSTOPERATIVE 26 0.0130
125 PARAESTHESIA ORAL 182 0.0126
126 ORAL CANDIDIASIS 164 0.0124
127 RHEUMATIC FEVER 55 0.0123
128 HYPOPHOSPHATAEMIA 91 0.0123
129 SENSITIVITY TO WEATHER CHANGE 64 0.0122
130 PRODUCT PACKAGE ASSOCIATED INJURY 27 0.0121
131 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 8 0.0120
132 HYPOSMIA 18 0.0120
133 ALANINE AMINOTRANSFERASE ABNORMAL 25 0.0118
134 DISLOCATION OF VERTEBRA 27 0.0118
135 ASTHMA 1338 0.0118
136 RHINALGIA 32 0.0116
137 PERIPHERAL VENOUS DISEASE 47 0.0115
138 VAGINAL DISCHARGE 116 0.0115
139 FIBROSIS 35 0.0114
140 RHINITIS 90 0.0112
141 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 793 0.0111
142 STENOTROPHOMONAS INFECTION 15 0.0111
143 SWOLLEN JOINT COUNT INCREASED 35 0.0110
144 CLEFT PALATE 21 0.0109
145 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 507 0.0108
146 NASAL DISCOMFORT 85 0.0107
147 OVERWEIGHT 57 0.0106
148 CARDIOGENIC SHOCK 152 0.0106
149 NASAL INFLAMMATION 11 0.0104
150 HYPOPITUITARISM 18 0.0103
151 OBSTRUCTION 41 0.0103
152 BLOOD TEST ABNORMAL 141 0.0100
153 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 50 0.0099
154 ONYCHOMADESIS 41 0.0098
155 NASAL SEPTUM DEVIATION 19 0.0097
156 HYPERCAPNIA 29 0.0096
157 SENSE OF OPPRESSION 11 0.0093
158 SARCOIDOSIS 44 0.0093
159 SECRETION DISCHARGE 114 0.0091
160 TASTE DISORDER 183 0.0090
161 SINUS PAIN 21 0.0090
162 NASAL PRURITUS 11 0.0088
163 CONJUNCTIVITIS ALLERGIC 13 0.0088
164 BLOODY DISCHARGE 10 0.0087
165 RESPIRATORY TRACT IRRITATION 9 0.0086
166 SEASONAL ALLERGY 120 0.0085
167 NASAL DISORDER 22 0.0083
168 LACTOSE INTOLERANCE 21 0.0082
169 PARANASAL SINUS DISCOMFORT 31 0.0082
170 GRANULOMA 28 0.0081
171 NEURITIS 12 0.0078
172 GESTATIONAL HYPERTENSION 10 0.0077
173 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 16 0.0077
174 FINGER DEFORMITY 37 0.0076
175 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 365 0.0076
176 PRODUCTIVE COUGH 362 0.0076
177 RALES 44 0.0076
178 DUODENAL ULCER PERFORATION 56 0.0075
179 ALLERGY TO ANIMAL 8 0.0075
180 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 388 0.0074
181 TROPONIN INCREASED 56 0.0074
182 BONE EROSION 26 0.0073
183 EOSINOPHIL COUNT INCREASED 61 0.0073
184 X-RAY ABNORMAL 13 0.0073
185 LOWER RESPIRATORY TRACT CONGESTION 12 0.0071
186 CUSHINGOID 22 0.0068
187 NASAL CONGESTION 400 0.0068
188 BREAST CANCER STAGE III 44 0.0068
189 TONGUE DRY 9 0.0066
190 RHEUMATOID FACTOR POSITIVE 38 0.0066
191 NASAL DISCHARGE DISCOLOURATION 9 0.0065
192 PLEURITIC PAIN 18 0.0065
193 EPILEPSY 198 0.0065
194 EXPOSURE TO SARS-COV-2 11 0.0065
195 PULMONARY FUNCTION TEST ABNORMAL 10 0.0064
196 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 46 0.0064
197 BRONCHIAL OBSTRUCTION 9 0.0064
198 NASAL DRYNESS 40 0.0064
199 ACUTE SINUSITIS 11 0.0064
200 TONGUE COATED 11 0.0064
201 RETINITIS 11 0.0064
202 INFUSION SITE REACTION 19 0.0064
203 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 109 0.0064
204 DYSPNOEA EXERTIONAL 238 0.0063
205 RESPIRATORY TRACT INFECTION 161 0.0062
206 SLEEP APNOEA SYNDROME 115 0.0060
207 PROCEDURAL PAIN 166 0.0060
208 RHINORRHOEA 385 0.0060
209 ORAL MUCOSAL EXFOLIATION 9 0.0059
210 TYMPANIC MEMBRANE PERFORATION 10 0.0059
211 BLOOD PRESSURE DIASTOLIC ABNORMAL 15 0.0059
212 BURSITIS 71 0.0058
213 PULMONARY PAIN 17 0.0058
214 SYNOVITIS 105 0.0058
215 VERTIGO POSITIONAL 10 0.0057
216 INFUSION SITE DISCHARGE 10 0.0057
217 OCULAR DISCOMFORT 64 0.0057
218 JOINT RANGE OF MOTION DECREASED 75 0.0056
219 BACTERIAL INFECTION 104 0.0056
220 SPUTUM INCREASED 12 0.0055
221 FREQUENT BOWEL MOVEMENTS 149 0.0055
222 GASTROOESOPHAGEAL REFLUX DISEASE 443 0.0055
223 LIVE BIRTH 46 0.0055
224 MULTIPLE ORGAN DYSFUNCTION SYNDROME 155 0.0055
225 FOLLICULITIS 57 0.0054
226 CONTRAINDICATED PRODUCT PRESCRIBED 9 0.0054
227 CARDIAC MURMUR 46 0.0053
228 RESPIRATORY DISORDER 159 0.0053
229 BODY TEMPERATURE DECREASED 52 0.0053
230 HYPERCHOLESTEROLAEMIA 51 0.0053
231 ASCITES 155 0.0053
232 ANOSMIA 76 0.0052
233 RESPIRATORY RATE INCREASED 46 0.0052
234 RENAL CYST 41 0.0052
235 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 150 0.0051
236 UPPER-AIRWAY COUGH SYNDROME 42 0.0051
237 SCIATICA 78 0.0049
238 PHARYNGEAL DISORDER 14 0.0049
239 NEURALGIA 118 0.0048
240 BLOOD CALCIUM INCREASED 42 0.0048
241 ULCER HAEMORRHAGE 32 0.0047
242 BLOOD PRESSURE SYSTOLIC INCREASED 92 0.0047
243 LUNG CONSOLIDATION 13 0.0046
244 PRODUCT LABEL CONFUSION 27 0.0046
245 INFUSION SITE BRUISING 10 0.0046
246 EMBOLISM VENOUS 14 0.0046
247 MULTI-ORGAN DISORDER 9 0.0046
248 HYPERLIPIDAEMIA 54 0.0045
249 BACK INJURY 49 0.0045
250 SNEEZING 101 0.0045
251 SINUS DISORDER 89 0.0045
252 DYSPNOEA AT REST 13 0.0045
253 PEMPHIGUS 56 0.0045
254 WOUND INFECTION 49 0.0045
255 MUSCLE INJURY 37 0.0045
256 LOWER RESPIRATORY TRACT INFECTION 203 0.0045
257 EMPHYSEMA 45 0.0045
258 BLOOD PRESSURE SYSTOLIC ABNORMAL 11 0.0044
259 NEPHROPATHY 41 0.0044
260 RESPIRATORY TRACT INFECTION VIRAL 10 0.0043
261 MIDDLE INSOMNIA 80 0.0043
262 EAR PRURITUS 15 0.0043
263 SNORING 16 0.0042
264 EOSINOPHILIA 74 0.0042
265 AFFECTIVE DISORDER 33 0.0042
266 EXOSTOSIS 38 0.0042
267 DERMATITIS ALLERGIC 52 0.0041
268 ECZEMA 215 0.0041
269 NECK INJURY 12 0.0041
270 JUVENILE IDIOPATHIC ARTHRITIS 10 0.0041
271 LIP DRY 37 0.0041
272 PURPURA 36 0.0041
273 BENIGN PROSTATIC HYPERPLASIA 21 0.0041
274 DEVICE INFUSION ISSUE 10 0.0040
275 OESOPHAGEAL CANDIDIASIS 16 0.0040
276 RECTAL HAEMORRHAGE 172 0.0040
277 INFUSION SITE HAEMORRHAGE 13 0.0039
278 INCREASED BRONCHIAL SECRETION 10 0.0039
279 OXYGEN SATURATION ABNORMAL 11 0.0039
280 GLAUCOMA 74 0.0038
281 SLEEP DISORDER 271 0.0038
282 PERICARDITIS 64 0.0038
283 FOOD ALLERGY 29 0.0038
284 LUNG NEOPLASM 16 0.0037
285 HYDRONEPHROSIS 28 0.0037
286 MYCOBACTERIUM AVIUM COMPLEX INFECTION 10 0.0037
287 INFUSION RELATED REACTION 246 0.0037
288 DRUG INTOLERANCE 358 0.0037
289 PULMONARY FIBROSIS 70 0.0036
290 SINUSITIS 371 0.0036
291 FRUSTRATION TOLERANCE DECREASED 29 0.0036
292 C-REACTIVE PROTEIN ABNORMAL 23 0.0036
293 EYE PRURITUS 120 0.0036
294 GOUT 64 0.0036
295 GASTROENTERITIS 52 0.0036
296 POLYDIPSIA 14 0.0035
297 OBESITY 56 0.0035
298 BLOOD COUNT ABNORMAL 53 0.0035
299 MENOPAUSE 9 0.0035
300 INFUSION SITE PRURITUS 11 0.0035
301 ASPIRATION 38 0.0035
302 COUGH 959 0.0034
303 DRY MOUTH 277 0.0034
304 COLITIS 129 0.0034
305 ULCER 54 0.0034
306 CHEST DISCOMFORT 347 0.0034
307 BODY HEIGHT DECREASED 36 0.0034
308 THERAPEUTIC PRODUCT INEFFECTIVE 13 0.0034
309 PRODUCT DISPENSING ERROR 73 0.0033
310 RESPIRATORY TRACT CONGESTION 53 0.0033
311 HYPONATRAEMIA 183 0.0032
312 BLOOD IMMUNOGLOBULIN G DECREASED 8 0.0032
313 PULMONARY MASS 48 0.0032
314 ABDOMINAL TENDERNESS 16 0.0032
315 COLITIS ULCERATIVE 144 0.0032
316 EAR DISCOMFORT 33 0.0032
317 DRUG TOLERANCE DECREASED 9 0.0032
318 BLOOD CHOLESTEROL INCREASED 148 0.0032
319 FOOT DEFORMITY 35 0.0032
320 EXERCISE TOLERANCE DECREASED 18 0.0031
321 FIBROMYALGIA 76 0.0031
322 PRESCRIBED OVERDOSE 60 0.0031
323 GLOSSODYNIA 69 0.0031
324 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 20 0.0031
325 IRRITABLE BOWEL SYNDROME 66 0.0031
326 MULTIPLE ALLERGIES 24 0.0031
327 DYSPHONIA 178 0.0030
328 DYSPEPSIA 299 0.0030
329 ANXIETY DISORDER 10 0.0030
330 PHARYNGITIS 37 0.0030
331 PRODUCT USE IN UNAPPROVED INDICATION 739 0.0030
332 HAEMOPTYSIS 83 0.0030
333 HAND DEFORMITY 39 0.0030
334 TYPE 2 DIABETES MELLITUS 100 0.0030
335 PULMONARY FUNCTION TEST DECREASED 13 0.0030
336 MIGRAINE 283 0.0030
337 HEPATIC STEATOSIS 55 0.0029
338 EPISTAXIS 220 0.0029
339 INCREASED UPPER AIRWAY SECRETION 15 0.0029
340 CHOKING SENSATION 16 0.0029
341 DIABETES MELLITUS 221 0.0029
342 ATELECTASIS 28 0.0029
343 PARANASAL SINUS HYPERSECRETION 11 0.0029
344 HAEMATOCHEZIA 159 0.0029
345 SUSPECTED OFF LABEL USE 13 0.0029
346 DYSPNOEA 1627 0.0029
347 LUPUS-LIKE SYNDROME 26 0.0029
348 IRON DEFICIENCY ANAEMIA 26 0.0028
349 GLOSSITIS 10 0.0028
350 ADRENAL INSUFFICIENCY 34 0.0028
351 END STAGE RENAL DISEASE 51 0.0028
352 PRODUCT DELIVERY MECHANISM ISSUE 15 0.0028
353 BRUXISM 15 0.0028
354 MATERNAL EXPOSURE BEFORE PREGNANCY 19 0.0028
355 BRONCHITIS 205 0.0028
356 SINUS CONGESTION 37 0.0027
357 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
358 ABSCESS 43 0.0027
359 RESTLESS LEGS SYNDROME 49 0.0027
360 THROAT IRRITATION 120 0.0027
361 OSTEOARTHRITIS 113 0.0027
362 SOCIAL PROBLEM 11 0.0027
363 LUNG DISORDER 130 0.0026
364 SARS-COV-2 TEST POSITIVE 35 0.0026
365 CONTRAINDICATED PRODUCT ADMINISTERED 80 0.0026
366 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
367 TONGUE DISORDER 19 0.0026
368 MUCOUS STOOLS 13 0.0026
369 EAR DISORDER 12 0.0026
370 SKIN ATROPHY 15 0.0026
371 APHONIA 36 0.0026
372 EXTRA DOSE ADMINISTERED 104 0.0026
373 DRY THROAT 26 0.0026
374 UPPER RESPIRATORY TRACT INFECTION 118 0.0026
375 OROPHARYNGEAL DISCOMFORT 23 0.0025
376 HAND FRACTURE 18 0.0025
377 DEVICE USE ERROR 88 0.0025
378 PAROSMIA 19 0.0025
379 TONGUE DISCOLOURATION 11 0.0025
380 PULMONARY ALVEOLAR HAEMORRHAGE 14 0.0025
381 MUSCULOSKELETAL PAIN 129 0.0025
382 BRONCHOSPASM 35 0.0025
383 POLYP 16 0.0024
384 DECREASED ACTIVITY 26 0.0024
385 JOINT STIFFNESS 63 0.0024
386 SINUS TACHYCARDIA 34 0.0024
387 PSORIATIC ARTHROPATHY 97 0.0024
388 INFUSION SITE SWELLING 15 0.0024
389 BLOOD PRESSURE DIASTOLIC INCREASED 11 0.0024
390 GAIT INABILITY 79 0.0024
391 DRUG EFFECT LESS THAN EXPECTED 35 0.0024
392 AUTOIMMUNE DISORDER 23 0.0024
393 RED BLOOD CELL SEDIMENTATION RATE INCREASED 26 0.0023
394 GINGIVAL DISORDER 9 0.0023
395 NEUROLOGICAL SYMPTOM 13 0.0023
396 ABDOMINAL DISTENSION 236 0.0023
397 INFUSION SITE EXTRAVASATION 14 0.0022
398 FACIAL PAIN 20 0.0022
399 BEHAVIOUR DISORDER 12 0.0022
400 CHEILITIS 12 0.0022
401 EAR PAIN 43 0.0022
402 SKIN LACERATION 24 0.0022
403 CHOKING 43 0.0022
404 PERIPHERAL ISCHAEMIA 9 0.0022
405 JOINT INJURY 47 0.0022
406 MICTURITION URGENCY 25 0.0022
407 AUTISM SPECTRUM DISORDER 12 0.0022
408 CORONARY ARTERY DISEASE 66 0.0022
409 PNEUMONIA BACTERIAL 20 0.0022
410 RESPIRATION ABNORMAL 15 0.0022
411 SYMPTOM RECURRENCE 13 0.0022
412 NAIL DISORDER 19 0.0022
413 EYE OPERATION 10 0.0022
414 AMYLASE INCREASED 8 0.0022
415 CANDIDA INFECTION 36 0.0021
416 ARTHROPATHY 118 0.0021
417 TONGUE DISCOMFORT 9 0.0021
418 ABDOMINAL PAIN 491 0.0021
419 INTERVERTEBRAL DISC DISORDER 9 0.0021
420 PRODUCT PRESCRIBING ERROR 50 0.0021
421 LIVER FUNCTION TEST INCREASED 45 0.0021
422 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15 0.0021
423 POLYARTHRITIS 11 0.0021
424 PNEUMONIA 675 0.0021
425 GENERAL PHYSICAL HEALTH DETERIORATION 240 0.0021
426 SWELLING 194 0.0021
427 ANKLE FRACTURE 32 0.0021
428 LIMB INJURY 56 0.0021
429 OROPHARYNGEAL PAIN 190 0.0021
430 CONJUNCTIVITIS 38 0.0020
431 AGEUSIA 51 0.0020
432 HELICOBACTER INFECTION 21 0.0020
433 OEDEMA 110 0.0020
434 NECK PAIN 113 0.0020
435 ILLNESS 208 0.0020
436 INFUSION SITE ERYTHEMA 17 0.0020
437 LIVER INJURY 49 0.0020
438 HEART RATE DECREASED 70 0.0020
439 MOVEMENT DISORDER 64 0.0020
440 VASCULAR DEVICE INFECTION 9 0.0020
441 PULMONARY CONGESTION 26 0.0020
442 OSTEOPOROSIS 81 0.0020
443 CONSTIPATION 424 0.0019
444 SYSTEMIC LUPUS ERYTHEMATOSUS 69 0.0019
445 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
446 BREAST MASS 13 0.0019
447 CONDITION AGGRAVATED 588 0.0019
448 WOUND 54 0.0019
449 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
450 DISABILITY 38 0.0019
451 INTENTIONAL UNDERDOSE 14 0.0019
452 TONSILLITIS 10 0.0019
453 SWELLING OF EYELID 12 0.0019
454 SEPSIS 213 0.0019
455 FOOD CRAVING 10 0.0019
456 PARAESTHESIA 297 0.0019
457 OXYGEN SATURATION DECREASED 106 0.0019
458 PRODUCT PRESCRIBING ISSUE 41 0.0019
459 HYPOAESTHESIA 281 0.0019
460 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 337 0.0019
461 EXPIRED PRODUCT ADMINISTERED 62 0.0019
462 ANAL FISSURE 10 0.0019
463 VIRAL INFECTION 62 0.0019
464 SKIN LESION 51 0.0019
465 LACRIMATION INCREASED 56 0.0019
466 INCORRECT PRODUCT ADMINISTRATION DURATION 40 0.0018
467 NIGHT SWEATS 59 0.0018
468 CATARACT 109 0.0018
469 ASPERGILLUS INFECTION 12 0.0018
470 TENDERNESS 19 0.0018
471 MENTAL IMPAIRMENT 44 0.0018
472 LUNG INFILTRATION 16 0.0018
473 ORAL DISCOMFORT 25 0.0018
474 INFLUENZA 200 0.0018
475 INFUSION SITE PAIN 23 0.0018
476 COVID-19 PNEUMONIA 21 0.0018
477 PNEUMOTHORAX 28 0.0018
478 CHEST PAIN 326 0.0018
479 PHLEBITIS 9 0.0018
480 STOMATITIS 106 0.0017
481 WEIGHT DECREASED 482 0.0017
482 HYPERVENTILATION 10 0.0017
483 HYPOKINESIA 25 0.0017
484 LIGAMENT SPRAIN 17 0.0017
485 HYPERTENSION 364 0.0017
486 LOWER LIMB FRACTURE 33 0.0017
487 RESPIRATORY DEPRESSION 21 0.0017
488 MEMORY IMPAIRMENT 235 0.0017
489 HIATUS HERNIA 22 0.0017
490 MUSCULOSKELETAL STIFFNESS 148 0.0017
491 TENDON DISORDER 11 0.0017
492 THYROID DISORDER 26 0.0017
493 SINUS HEADACHE 10 0.0017
494 DYSSTASIA 49 0.0017
495 IMMUNODEFICIENCY 25 0.0017
496 NASOPHARYNGITIS 309 0.0017
497 IMPAIRED QUALITY OF LIFE 24 0.0017
498 INTENTIONAL PRODUCT MISUSE 146 0.0017
499 GASTROENTERITIS VIRAL 30 0.0017
500 BONE DENSITY DECREASED 52 0.0017
501 APPETITE DISORDER 11 0.0017
502 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
503 IMPAIRED HEALING 54 0.0016
504 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0016
505 POST-TRAUMATIC STRESS DISORDER 11 0.0016
506 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 90 0.0016
507 PHARYNGEAL SWELLING 16 0.0016
508 GINGIVAL PAIN 13 0.0016
509 PSYCHIATRIC SYMPTOM 12 0.0016
510 LIVER DISORDER 72 0.0016
511 OCULAR HYPERAEMIA 77 0.0016
512 ARTHROPOD BITE 12 0.0016
513 EAR INFECTION 43 0.0016
514 TENDONITIS 25 0.0016
515 ABDOMINAL PAIN UPPER 332 0.0016
516 DRUG INEFFECTIVE 2122 0.0016
517 JOINT DISLOCATION 17 0.0016
518 THROMBOSIS 129 0.0016
519 PERIORBITAL SWELLING 9 0.0016
520 GRIP STRENGTH DECREASED 14 0.0016
521 SWELLING FACE 103 0.0016
522 HERPES ZOSTER 90 0.0016
523 THROAT TIGHTNESS 42 0.0016
524 CONCUSSION 12 0.0015
525 PRODUCT QUALITY ISSUE 210 0.0015
526 THERAPEUTIC PRODUCT EFFECT DECREASED 69 0.0015
527 C-REACTIVE PROTEIN INCREASED 56 0.0015
528 HEPATITIS ACUTE 10 0.0015
529 PULMONARY EMBOLISM 145 0.0015
530 ANAEMIA 291 0.0015
531 CHOLELITHIASIS 50 0.0015
532 PSEUDOMONAS INFECTION 13 0.0015
533 CARDIAC PACEMAKER INSERTION 9 0.0015
534 UTERINE LEIOMYOMA 11 0.0015
535 MUSCULOSKELETAL CHEST PAIN 23 0.0015
536 PRODUCT ADMINISTRATION ERROR 30 0.0015
537 LUNG NEOPLASM MALIGNANT 61 0.0015
538 MALAISE 650 0.0015
539 ASTHENOPIA 8 0.0015
540 PERIPHERAL SWELLING 224 0.0015
541 MATERNAL EXPOSURE DURING PREGNANCY 129 0.0014
542 PRODUCT DOSE OMISSION ISSUE 425 0.0014
543 SKIN DISORDER 48 0.0014
544 HIP ARTHROPLASTY 22 0.0014
545 DEFAECATION URGENCY 10 0.0014
546 ADVERSE DRUG REACTION 128 0.0014
547 BLISTER 80 0.0014
548 HEAD INJURY 45 0.0014
549 HEART RATE INCREASED 140 0.0014
550 LIP SWELLING 47 0.0014
551 PRESCRIBED UNDERDOSE 28 0.0014
552 DERMATITIS CONTACT 16 0.0014
553 PROCTALGIA 9 0.0014
554 LOW BIRTH WEIGHT BABY 11 0.0014
555 SWOLLEN TONGUE 43 0.0014
556 DYSGRAPHIA 9 0.0014
557 SENSITIVE SKIN 10 0.0014
558 POOR VENOUS ACCESS 14 0.0014
559 HYPERSENSITIVITY 251 0.0014
560 ILL-DEFINED DISORDER 82 0.0013
561 ASPHYXIA 11 0.0013
562 MALNUTRITION 15 0.0013
563 BLOOD PRESSURE FLUCTUATION 32 0.0013
564 BLOOD CREATININE INCREASED 87 0.0013
565 OEDEMA PERIPHERAL 162 0.0013
566 AKATHISIA 18 0.0013
567 DRY EYE 65 0.0013
568 VOMITING 608 0.0013
569 THERAPEUTIC RESPONSE UNEXPECTED 58 0.0013
570 SOMNOLENCE 260 0.0013
571 VASCULITIS 15 0.0013
572 MENTAL DISORDER 56 0.0013
573 CONTUSION 123 0.0013
574 HEPATIC CIRRHOSIS 24 0.0013
575 ARTERIAL OCCLUSIVE DISEASE 10 0.0013
576 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 257 0.0013
577 TRICUSPID VALVE INCOMPETENCE 10 0.0013
578 ARTHRITIS 99 0.0013
579 POOR QUALITY SLEEP 27 0.0013
580 DERMATITIS ATOPIC 66 0.0013
581 PYREXIA 433 0.0013
582 EYE DISCHARGE 13 0.0012
583 PRODUCT USE ISSUE 235 0.0012
584 HEAD DISCOMFORT 22 0.0012
585 SENSORY LOSS 10 0.0012
586 PERIPHERAL COLDNESS 17 0.0012
587 NEEDLE ISSUE 36 0.0012
588 OFF LABEL USE 1078 0.0012
589 VITAMIN D DEFICIENCY 12 0.0012
590 PRODUCT DOSE OMISSION 80 0.0012
591 COELIAC DISEASE 12 0.0012
592 INTENTIONAL PRODUCT USE ISSUE 107 0.0012
593 POLYURIA 10 0.0012
594 PARANOIA 21 0.0012
595 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
596 ERYTHEMA 248 0.0012
597 MADAROSIS 14 0.0012
598 WEIGHT INCREASED 270 0.0012
599 MUSCULAR WEAKNESS 137 0.0012
600 BREAST CANCER STAGE II 10 0.0012
601 URTICARIA 201 0.0012
602 ANGIOEDEMA 53 0.0012
603 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
604 ABDOMINAL PAIN LOWER 30 0.0012
605 COVID-19 208 0.0012
606 PLEURAL EFFUSION 72 0.0012
607 BOWEL MOVEMENT IRREGULARITY 9 0.0012
608 HEPATIC ENZYME INCREASED 80 0.0012
609 BACK DISORDER 19 0.0012
610 PERICARDIAL EFFUSION 27 0.0012
611 INFLAMMATION 60 0.0012
612 LOCALISED INFECTION 28 0.0012
613 INTENTIONAL DOSE OMISSION 33 0.0012
614 PAIN 711 0.0012
615 HEADACHE 722 0.0012
616 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
617 SPINAL OSTEOARTHRITIS 10 0.0011
618 BLOOD PRESSURE INCREASED 174 0.0011
619 APPLICATION SITE REACTION 8 0.0011
620 MOOD ALTERED 31 0.0011
621 HYPOXIA 40 0.0011
622 EYE SWELLING 42 0.0011
623 ANAL INCONTINENCE 10 0.0011
624 PHARYNGITIS STREPTOCOCCAL 12 0.0011
625 BIPOLAR DISORDER 12 0.0011
626 FEELING JITTERY 21 0.0011
627 OVARIAN CYST 11 0.0011
628 ABNORMAL FAECES 9 0.0011
629 NIGHTMARE 38 0.0011
630 PRODUCT AVAILABILITY ISSUE 25 0.0011
631 DYSPHAGIA 104 0.0011
632 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 37 0.0011
633 ACUTE RESPIRATORY FAILURE 21 0.0011
634 MOUTH ULCERATION 23 0.0011
635 HEMIPLEGIA 9 0.0011
636 TRANSAMINASES INCREASED 24 0.0011
637 RETCHING 23 0.0011
638 PRODUCT DISTRIBUTION ISSUE 10 0.0011
639 HAEMORRHOIDS 21 0.0011
640 ANAPHYLACTIC REACTION 59 0.0011
641 FLANK PAIN 10 0.0011
642 FACIAL PARALYSIS 9 0.0011
643 ABNORMAL DREAMS 29 0.0010
644 EYE INFLAMMATION 10 0.0010
645 EXPOSURE DURING PREGNANCY 65 0.0010
646 THERAPY NON-RESPONDER 47 0.0010
647 JOINT SWELLING 126 0.0010
648 MYOPATHY 9 0.0010
649 ANXIETY 296 0.0010
650 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
651 SINUS BRADYCARDIA 10 0.0010
652 CYTOMEGALOVIRUS INFECTION 17 0.0010
653 INSOMNIA 272 0.0010
654 PRODUCT COMMUNICATION ISSUE 9 0.0010
655 DISCOMFORT 62 0.0010
656 HOSPITALISATION 156 0.0010
657 UNDERDOSE 74 0.0010
658 MOBILITY DECREASED 72 0.0010
659 PALPITATIONS 117 0.0010
660 MUSCLE TWITCHING 23 0.0010
661 BACK PAIN 231 0.0010
662 SKIN REACTION 14 0.0010
663 FUNGAL INFECTION 33 0.0010
664 GASTRITIS 26 0.0010
665 RHEUMATOID ARTHRITIS 111 0.0010
666 DISEASE RECURRENCE 46 0.0010
667 DEPRESSION 220 0.0010
668 MYALGIA 164 0.0010
669 BRAIN FOG 15 0.0010
670 LACERATION 9 0.0010
671 INJECTION SITE DISCOMFORT 10 0.0009
672 KNEE ARTHROPLASTY 20 0.0009
673 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
674 INFECTION 137 0.0009
675 PREMATURE DELIVERY 15 0.0009
676 CIRCULATORY COLLAPSE 16 0.0009
677 DRUG EFFECT INCOMPLETE 34 0.0009
678 ROTATOR CUFF SYNDROME 12 0.0009
679 ARTHRALGIA 388 0.0009
680 NAUSEA 735 0.0009
681 DIZZINESS POSTURAL 9 0.0009
682 GASTROINTESTINAL DISORDER 83 0.0009
683 TINNITUS 42 0.0009
684 EYE DISORDER 30 0.0009
685 PHARYNGEAL OEDEMA 14 0.0009
686 EYE HAEMORRHAGE 12 0.0009
687 FOOT FRACTURE 17 0.0009
688 PRODUCT USE COMPLAINT 14 0.0009
689 EYE INFECTION 10 0.0009
690 BODY TEMPERATURE INCREASED 18 0.0009
691 CYSTITIS 28 0.0009
692 MUSCLE SPASMS 161 0.0009
693 INCORRECT DOSE ADMINISTERED 199 0.0009
694 PULMONARY OEDEMA 39 0.0009
695 DIZZINESS 433 0.0009
696 TREMOR 143 0.0009
697 ECONOMIC PROBLEM 13 0.0009
698 INJURY 60 0.0009
699 ATRIAL FIBRILLATION 83 0.0009
700 COLD SWEAT 15 0.0009
701 ASTHENIA 320 0.0009
702 MANIA 14 0.0009
703 ARTERIOSCLEROSIS 8 0.0008
704 RENAL PAIN 9 0.0008
705 CONFUSIONAL STATE 136 0.0008
706 POLLAKIURIA 35 0.0008
707 PRURITUS 322 0.0008
708 LUNG INFECTION 13 0.0008
709 ABDOMINAL DISCOMFORT 140 0.0008
710 WRIST FRACTURE 10 0.0008
711 CELLULITIS 42 0.0008
712 HYPERTHYROIDISM 12 0.0008
713 TOOTHACHE 15 0.0008
714 PANIC ATTACK 30 0.0008
715 NERVOUSNESS 43 0.0008
716 EYE PAIN 46 0.0008
717 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
718 TACHYPNOEA 11 0.0008
719 GENERALISED OEDEMA 10 0.0008
720 ACCIDENTAL EXPOSURE TO PRODUCT 83 0.0008
721 VERTIGO 49 0.0008
722 ANGINA PECTORIS 23 0.0008
723 RASH MACULAR 28 0.0008
724 REBOUND EFFECT 9 0.0008
725 MITRAL VALVE INCOMPETENCE 9 0.0008
726 ACCIDENTAL OVERDOSE 29 0.0008
727 FEELING COLD 22 0.0008
728 SCAB 9 0.0008
729 INSURANCE ISSUE 12 0.0008
730 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
731 FATIGUE 610 0.0008
732 HYPOTHYROIDISM 25 0.0008
733 BLOOD PRESSURE DECREASED 52 0.0008
734 DYSGEUSIA 58 0.0008
735 PAIN IN EXTREMITY 230 0.0008
736 URINARY RETENTION 26 0.0008
737 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
738 INJECTION SITE INDURATION 10 0.0008
739 FACE OEDEMA 13 0.0008
740 HOT FLUSH 58 0.0008
741 PARALYSIS 11 0.0008
742 PRODUCT STORAGE ERROR 67 0.0008
743 BLOOD POTASSIUM DECREASED 23 0.0008
744 TOOTH DISORDER 17 0.0008
745 GAIT DISTURBANCE 146 0.0008
746 RESPIRATORY DISTRESS 21 0.0008
747 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
748 BACTERAEMIA 9 0.0008
749 MUSCULOSKELETAL DISCOMFORT 13 0.0008
750 ADVERSE REACTION 10 0.0008
751 ROAD TRAFFIC ACCIDENT 31 0.0007
752 MUSCLE TIGHTNESS 12 0.0007
753 BALANCE DISORDER 64 0.0007
754 ANGER 25 0.0007
755 ARRHYTHMIA 35 0.0007
756 LYMPHADENOPATHY 26 0.0007
757 FEELING HOT 45 0.0007
758 IMPAIRED GASTRIC EMPTYING 10 0.0007
759 BONE LOSS 11 0.0007
760 RIB FRACTURE 15 0.0007
761 TENDON RUPTURE 9 0.0007
762 VISION BLURRED 100 0.0007
763 DRUG INTERACTION 115 0.0007
764 URINARY TRACT INFECTION 123 0.0007
765 RASH PRURITIC 39 0.0007
766 SYNCOPE 72 0.0007
767 CHILLS 84 0.0007
768 HIP FRACTURE 23 0.0007
769 HALLUCINATION, VISUAL 15 0.0007
770 THERAPEUTIC RESPONSE DECREASED 43 0.0007
771 FEAR 19 0.0007
772 FLATULENCE 40 0.0007
773 BLOOD GLUCOSE ABNORMAL 13 0.0007
774 PANCREATITIS 37 0.0007
775 IRRITABILITY 42 0.0007
776 ANAPHYLACTIC SHOCK 18 0.0007
777 THINKING ABNORMAL 13 0.0007
778 HYPERSOMNIA 20 0.0007
779 AMNESIA 45 0.0007
780 DELIRIUM 24 0.0007
781 DYSARTHRIA 26 0.0007
782 NODULE 9 0.0007
783 ORTHOSTATIC HYPOTENSION 12 0.0007
784 DISTURBANCE IN ATTENTION 37 0.0007
785 DIVERTICULITIS 19 0.0007
786 IMMUNE SYSTEM DISORDER 9 0.0007
787 ACUTE MYOCARDIAL INFARCTION 20 0.0007
788 DRUG ERUPTION 12 0.0007
789 RASH 294 0.0007
790 BLOOD IRON DECREASED 8 0.0007
791 DIARRHOEA 434 0.0007
792 DECREASED APPETITE 156 0.0007
793 THIRST 12 0.0007
794 ACCIDENT 8 0.0007
795 VISUAL IMPAIRMENT 83 0.0007
796 PHOTOSENSITIVITY REACTION 11 0.0007
797 CHROMATURIA 15 0.0007
798 HEART RATE IRREGULAR 15 0.0007
799 HYPOAESTHESIA ORAL 10 0.0007
800 KIDNEY INFECTION 13 0.0007
801 PNEUMONITIS 18 0.0007
802 FALL 219 0.0007
803 HAEMATOMA 17 0.0007
804 INFLUENZA LIKE ILLNESS 54 0.0007
805 NEPHROLITHIASIS 30 0.0007
806 PREGNANCY 13 0.0006
807 MYOCARDIAL INFARCTION 113 0.0006
808 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
809 DEPRESSED MOOD 34 0.0006
810 EYE IRRITATION 37 0.0006
811 BLOOD SODIUM DECREASED 12 0.0006
812 CYANOSIS 10 0.0006
813 BREAST CANCER 59 0.0006
814 BONE PAIN 37 0.0006
815 CARDIOVASCULAR DISORDER 16 0.0006
816 INCREASED APPETITE 12 0.0006
817 FOETAL EXPOSURE DURING PREGNANCY 51 0.0006
818 HERNIA 12 0.0006
819 PRESYNCOPE 15 0.0006
820 INJECTION SITE ERYTHEMA 76 0.0006
821 DEAFNESS 16 0.0006
822 CARDIOMYOPATHY 9 0.0006
823 BEDRIDDEN 8 0.0006
824 HYPOACUSIS 26 0.0006
825 TREATMENT FAILURE 50 0.0006
826 INTENTIONAL SELF-INJURY 12 0.0006
827 ACNE 45 0.0006
828 OSTEOPENIA 9 0.0006
829 HAEMATEMESIS 15 0.0006
830 CARDIAC DISORDER 55 0.0006
831 RENAL FAILURE 78 0.0006
832 PHOTOPHOBIA 11 0.0006
833 BURNING SENSATION 41 0.0006
834 THERAPY CESSATION 30 0.0006
835 SCAR 10 0.0006
836 HAEMATURIA 20 0.0006
837 SURGERY 34 0.0006
838 BASAL CELL CARCINOMA 9 0.0006
839 SPEECH DISORDER 30 0.0006
840 ALOPECIA 112 0.0006
841 FEELING ABNORMAL 136 0.0006
842 BLINDNESS UNILATERAL 8 0.0006
843 TARDIVE DYSKINESIA 16 0.0006
844 PREMATURE BABY 17 0.0006
845 EATING DISORDER 12 0.0006
846 SKIN FISSURES 11 0.0006
847 AGITATION 41 0.0006
848 SKIN CANCER 12 0.0006
849 BLOOD BILIRUBIN INCREASED 15 0.0006
850 SEPTIC SHOCK 24 0.0006
851 FLUID RETENTION 28 0.0005
852 ABORTION SPONTANEOUS 22 0.0005
853 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
854 HYPERGLYCAEMIA 20 0.0005
855 RENAL IMPAIRMENT 46 0.0005
856 OVERDOSE 118 0.0005
857 ERECTILE DYSFUNCTION 14 0.0005
858 HYPOTENSION 109 0.0005
859 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
860 ORAL PAIN 12 0.0005
861 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 38 0.0005
862 ANHEDONIA 14 0.0005
863 FRACTURE 10 0.0005
864 NEUROPATHY PERIPHERAL 50 0.0005
865 MUSCULOSKELETAL DISORDER 10 0.0005
866 DERMATITIS 11 0.0005
867 RESTLESSNESS 19 0.0005
868 INTERSTITIAL LUNG DISEASE 25 0.0005
869 LIVER FUNCTION TEST ABNORMAL 15 0.0005
870 INJECTION SITE BRUISING 41 0.0005
871 TREATMENT NONCOMPLIANCE 28 0.0005
872 PSYCHOTIC DISORDER 15 0.0005
873 BLOOD PRESSURE ABNORMAL 10 0.0005
874 UPPER LIMB FRACTURE 10 0.0005
875 DIPLOPIA 13 0.0005
876 DIABETIC KETOACIDOSIS 12 0.0005
877 PAIN IN JAW 14 0.0005
878 INJECTION SITE PRURITUS 33 0.0005
879 DRUG DOSE OMISSION 81 0.0005
880 DYSURIA 18 0.0005
881 INJECTION SITE RASH 15 0.0005
882 EMOTIONAL DISORDER 15 0.0005
883 MEDICATION ERROR 27 0.0005
884 HYPERHIDROSIS 62 0.0005
885 PULMONARY HYPERTENSION 10 0.0005
886 ABNORMAL BEHAVIOUR 19 0.0005
887 DISORIENTATION 19 0.0005
888 INTESTINAL OBSTRUCTION 18 0.0005
889 BLOOD URINE PRESENT 9 0.0005
890 URINARY INCONTINENCE 14 0.0005
891 SUICIDAL IDEATION 43 0.0005
892 HYPOPHAGIA 12 0.0005
893 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
894 HEPATITIS 12 0.0005
895 DRUG PRESCRIBING ERROR 9 0.0005
896 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
897 PRURITUS GENERALISED 10 0.0005
898 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
899 FAECES DISCOLOURED 10 0.0005
900 CARDIAC FAILURE CONGESTIVE 37 0.0005
901 AMENORRHOEA 8 0.0005
902 HYPOKALAEMIA 21 0.0005
903 TACHYCARDIA 40 0.0004
904 COGNITIVE DISORDER 21 0.0004
905 SPINAL FRACTURE 9 0.0004
906 LABORATORY TEST ABNORMAL 13 0.0004
907 PNEUMONIA ASPIRATION 11 0.0004
908 DEVICE DELIVERY SYSTEM ISSUE 12 0.0004
909 SKIN DISCOLOURATION 20 0.0004
910 LETHARGY 25 0.0004
911 PSORIASIS 56 0.0004
912 UNRESPONSIVE TO STIMULI 11 0.0004
913 FEMUR FRACTURE 13 0.0004
914 DRUG-INDUCED LIVER INJURY 13 0.0004
915 ADVERSE EVENT 38 0.0004
916 DEHYDRATION 54 0.0004
917 INJECTION SITE SWELLING 31 0.0004
918 RASH MACULO-PAPULAR 9 0.0004
919 SEIZURE 46 0.0004
920 HALLUCINATION 30 0.0004
921 RESPIRATORY FAILURE 29 0.0004
922 BLINDNESS 16 0.0004
923 HYPOGLYCAEMIA 19 0.0004
924 DEEP VEIN THROMBOSIS 25 0.0004
925 LOSS OF CONSCIOUSNESS 49 0.0004
926 LEUKOPENIA 19 0.0004
927 INJECTION SITE MASS 14 0.0004
928 INJECTION SITE PAIN 116 0.0004
929 CARDIAC FAILURE 30 0.0004
930 PALLOR 10 0.0004
931 DRY SKIN 49 0.0004
932 FLUSHING 37 0.0004
933 VISUAL ACUITY REDUCED 12 0.0004
934 MULTIPLE SCLEROSIS 17 0.0004
935 EMOTIONAL DISTRESS 43 0.0004
936 THERAPY INTERRUPTED 25 0.0003
937 SKIN ULCER 9 0.0003
938 PRODUCT SUBSTITUTION ISSUE 20 0.0003
939 METABOLIC ACIDOSIS 11 0.0003
940 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
941 BRADYCARDIA 18 0.0003
942 INJECTION SITE REACTION 23 0.0003
943 STAPHYLOCOCCAL INFECTION 11 0.0003
944 RENAL FAILURE ACUTE 14 0.0003
945 RENAL DISORDER 15 0.0003
946 ACUTE KIDNEY INJURY 49 0.0003
947 HAEMORRHAGE 33 0.0003
948 RASH ERYTHEMATOUS 15 0.0003
949 PANCREATIC CARCINOMA 9 0.0003
950 BLOOD GLUCOSE INCREASED 58 0.0003
951 FEBRILE NEUTROPENIA 20 0.0003
952 DRUG EFFECT DECREASED 16 0.0003
953 SKIN EXFOLIATION 25 0.0003
954 SKIN BURNING SENSATION 21 0.0003
955 GASTRIC DISORDER 10 0.0003
956 LIMB DISCOMFORT 9 0.0003
957 PANCYTOPENIA 16 0.0003
958 MOOD SWINGS 9 0.0003
959 AGGRESSION 14 0.0003
960 CEREBRAL HAEMORRHAGE 10 0.0003
961 THROMBOCYTOPENIA 31 0.0003
962 DYSKINESIA 11 0.0003
963 APHASIA 8 0.0003
964 HAEMOGLOBIN DECREASED 27 0.0003
965 WITHDRAWAL SYNDROME 11 0.0003
966 SKIN IRRITATION 12 0.0003
967 NEUTROPENIA 35 0.0003
968 CEREBROVASCULAR ACCIDENT 41 0.0002
969 VAGINAL HAEMORRHAGE 10 0.0002
970 DRUG ABUSE 19 0.0002
971 DISEASE PROGRESSION 27 0.0002
972 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
973 TOXICITY TO VARIOUS AGENTS 38 0.0002
974 DEATH 194 0.0002
975 CHRONIC KIDNEY DISEASE 17 0.0002
976 DEVICE ISSUE 19 0.0002
977 DRUG DEPENDENCE 34 0.0002
978 NEOPLASM MALIGNANT 14 0.0002
979 DEVICE LEAKAGE 9 0.0002
980 PLATELET COUNT DECREASED 22 0.0002
981 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
982 UNEVALUABLE EVENT 14 0.0002
983 CARDIAC ARREST 15 0.0002
984 INJECTION SITE HAEMORRHAGE 14 0.0002
985 BLOOD GLUCOSE DECREASED 8 0.0002
986 DEVICE MALFUNCTION 10 0.0001
987 BLADDER CANCER 8 0.0001
988 NO ADVERSE EVENT 24 0.0001
989 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
990 DRUG DOSE OMISSION BY DEVICE 9 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 9 0.0001